Beam Therapeutics, Inc. (BEAM)
26.92
+0.93
(+3.58%)
USD |
NASDAQ |
Feb 12, 16:00
26.99
+0.07
(+0.26%)
After-Hours: 19:51
Beam Therapeutics EPS Diluted (Quarterly) : -1.099 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.9196 |
| Pacific Biosciences of California, Inc. | -0.1263 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Twist Bioscience Corp. | -0.4995 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -112.73M |
| Revenue (Quarterly) | 9.698M |
| Total Expenses (Quarterly) | 122.43M |
| Enterprise Value | 1.714B |
| Gross Profit Margin (Quarterly) | 42.67% |
| Profit Margin (Quarterly) | -1.16K% |
| Earnings Yield | -16.47% |
| Normalized Earnings Yield | -16.66 |